Fluticasone Furoate -Vilanterol 100mcg-25mcg
In StockFluticasone Furoate 100 mcg–Vilanterol 25 mcg Inhalation Powder combines an inhaled corticosteroid with a long-acting bronchodilator for maintenance treatment of asthma or COPD. It is not intended to relieve sudden breathing symptoms.
| Active Ingredient: | Fluticasone Furoate + Vilanterol |
|---|---|
| Indication: | COPD |
| Strength: | 100mcg-25mcg |
| Dosage Form: | Tablets |
| Manufacturer: | Cipla Limited |
Fluticasone Furoate-Vilanterol 100mcg-25mcg – Quick Overview
Fluticasone Furoate-Vilanterol 100mcg-25mcg is an inhaled combination medicine (Breo Ellipta®) used for the maintenance treatment of COPD and asthma. Fluticasone furoate is a corticosteroid that reduces airway inflammation, while vilanterol is a long-acting bronchodilator that relaxes airway muscles. This is a prescription-only inhaler with an FDA boxed warning and is not for relief of sudden breathing problems.
Medical Supervision & Regulatory Status
Fluticasone Furoate-Vilanterol 100mcg-25mcg is FDA-approved and available only by prescription in the United States. It carries an FDA boxed warning regarding increased risk of asthma-related death associated with long-acting beta2-agonists (LABAs), so medical supervision is required before starting and throughout treatment.
Clinical Context
Chronic obstructive pulmonary disease (COPD) and asthma both involve airway inflammation and narrowing that make breathing difficult, with COPD typically progressive and often linked to smoking history, while asthma can involve episodic flare-ups triggered by allergens or irritants. Left inadequately controlled, both conditions can lead to worsening lung function and more frequent exacerbations.
Combining an inhaled corticosteroid with a long-acting bronchodilator is a treatment strategy used for long-term maintenance control, because it addresses both underlying airway inflammation and ongoing airway narrowing at once, rather than relying on either mechanism alone.
Fluticasone furoate-vilanterol fits into therapy as a once-daily maintenance inhaler, used in COPD patients and in asthma patients (age 5 and older) whose condition isn’t adequately controlled on an inhaled corticosteroid alone, but it is not intended for relieving sudden asthma attacks or acute COPD symptoms.
How Fluticasone Furoate-Vilanterol 100mcg-25mcg Works
Fluticasone furoate belongs to the corticosteroid class and works by reducing inflammation in the airways, decreasing swelling and mucus production that contribute to breathing difficulty.
Vilanterol belongs to the long-acting beta2-adrenergic agonist (LABA) class and works by relaxing the smooth muscles around the airways, keeping them open for an extended period after each dose.
Together, these complementary mechanisms reduce airway inflammation while keeping airways open, helping improve lung function and reduce symptoms and flare-ups over the course of daily use.
What is Fluticasone Furoate-Vilanterol 100mcg-25mcg?
- Drug Class: Inhaled corticosteroid (ICS) + long-acting beta2-adrenergic agonist (LABA)
- Active Ingredients: Fluticasone furoate 100mcg, Vilanterol 25mcg (as vilanterol trifenatate)
- Mechanism: Fluticasone furoate reduces airway inflammation; vilanterol relaxes airway smooth muscle for prolonged bronchodilation.
- Form: Dry powder inhaler (oral inhalation)
- Dosing Frequency: One inhalation once daily, at the same time each day
- Regulatory Status: FDA-approved, prescription-only (Rx)
Uses / Indications
- Maintenance treatment of COPD: Helps improve airflow and reduce exacerbations in chronic obstructive pulmonary disease.
- Maintenance treatment of asthma: Used in patients aged 5 years and older whose asthma isn’t adequately controlled on an inhaled corticosteroid alone.
Not indicated for relief of acute bronchospasm or sudden breathing problems — a fast-acting rescue inhaler should be used for those situations.
How to Use / Dosage
Fluticasone Furoate-Vilanterol 100mcg-25mcg is taken as one inhalation once daily, at the same time each day, using the Ellipta inhaler device as directed by a physician or pharmacist. It should not be used more than once every 24 hours or with additional inhalations, as this increases the risk of side effects without added benefit. If shortness of breath occurs between scheduled doses, a separate fast-acting rescue inhaler should be used. If a dose is missed, take it as soon as remembered, then resume the normal once-daily schedule — do not double up. Do not stop this medication suddenly without consulting your doctor, as this can lead to worsening of underlying COPD or asthma symptoms.
Side Effects
Most people tolerate this inhaler reasonably well, though side effects can occur and should be discussed with a doctor. Common effects may include headache, upper respiratory infection symptoms, throat irritation, and oral thrush (candidiasis) in the mouth or throat. Serious effects, though less common, may include worsening asthma symptoms, pneumonia in COPD patients, increased heart rate, and, rarely, adrenal suppression with long-term use.
Emergency Warning Signs — Seek immediate medical care if you experience:
- Worsening shortness of breath or wheezing shortly after use (paradoxical bronchospasm)
- Chest pain or rapid, irregular heartbeat
- Signs of a severe allergic reaction (swelling of the face, lips, tongue, or throat; difficulty breathing; hives)
- Vision changes, eye pain, or halos around lights (possible glaucoma symptoms)
- Signs of infection such as fever with productive cough (possible pneumonia)
- White patches or soreness in the mouth (possible thrush)
- Significant, unexplained increase in symptoms requiring more rescue inhaler use
Warnings & Precautions
Fluticasone Furoate-Vilanterol 100mcg-25mcg carries an FDA boxed warning: long-acting beta2-agonists like vilanterol increase the risk of asthma-related death, based on data from a related LABA. It is contraindicated in patients with severe hypersensitivity to milk proteins or any ingredient in the formulation, since the powder formulation contains lactose. It should not be used as the primary treatment for status asthmaticus or other acute episodes requiring intensive measures. Drug interactions are relevant with strong CYP3A4 inhibitors, which can increase systemic exposure to both components and raise the risk of side effects, and with other medications affecting heart rhythm or containing additional LABAs, which should generally be avoided in combination. Use during pregnancy or breastfeeding should be discussed with a physician, as beta-agonists may affect uterine contractility during labor and safety data in breastfeeding are limited. Special populations, including patients with cardiovascular disease, seizure disorders, thyroid disorders, or diabetes, require closer monitoring due to systemic effects of the corticosteroid and LABA components. Regular monitoring of lung function and periodic eye exams for long-term users are generally recommended during therapy.
Who Should Not Use This Medication
- People with severe hypersensitivity to milk proteins or any ingredient in the formulation
- Individuals relying on it for relief of sudden asthma attacks or acute COPD symptoms
- Patients in status asthmaticus or other acute respiratory episodes requiring intensive care
- Anyone already using another medicine containing a LABA
- Patients with a known hypersensitivity to fluticasone furoate or vilanterol
Storage Instructions
Store the Fluticasone Furoate-Vilanterol 100mcg-25mcg inhaler at room temperature, away from excess heat and moisture. Keep the inhaler in its sealed tray until ready for use, and discard 6 weeks after opening the tray or when the counter reads zero, whichever comes first. Keep out of reach of children and pets, and dispose of the used inhaler appropriately.
Frequently Asked Questions
What is the cost of Fluticasone Furoate-Vilanterol 100mcg-25mcg without insurance?
The cost without insurance depends on the seller, brand availability, and pack size, and may also vary by location and available discounts. Manufacturer savings programs may also affect out-of-pocket cost.
How can I order Fluticasone Furoate-Vilanterol 100mcg-25mcg online?
A valid prescription is required to order this medication. Typically, you upload a prescription or have your doctor send it directly, then order from a licensed pharmacy for home delivery. Always verify the pharmacy is properly licensed before ordering.
Is Fluticasone Furoate-Vilanterol 100mcg-25mcg available over the counter?
No, it is not available over the counter in the United States or most other countries. Regulations may vary by region, but medical supervision is required due to its boxed warning.
Does Fluticasone Furoate-Vilanterol 100mcg-25mcg require a prescription?
Yes, a prescription is required. This ensures proper evaluation of your COPD or asthma severity before starting, along with ongoing monitoring for safety.
How long does it take to work?
This inhaler begins improving lung function within hours of the first dose, though the full maintenance benefit for symptom control is typically seen over the first one to two weeks of consistent daily use.
Can I stop taking this medication suddenly?
No, stopping suddenly without medical advice can lead to worsening of your underlying COPD or asthma. Any changes to your regimen should be guided by your doctor.
Does this medication interact with other drugs?
Yes, it can interact with strong CYP3A4 inhibitors, other LABA-containing medicines, and certain heart rhythm medications. Always tell your doctor about all medications you take before starting therapy.
Resources
- MedlinePlus – Fluticasone and Vilanterol Oral Inhalation: https://medlineplus.gov/druginfo/meds/a613048.html
- FDA – BREO ELLIPTA Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204275s012lbl.pdf
- DailyMed (NIH) – BREO ELLIPTA Label: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96428df1-ea05-431a-98d3-1ec2c4b63878
References
- FDA – BREO ELLIPTA Full Prescribing Information, including Boxed Warning: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204275s012lbl.pdf
- DailyMed (NIH) – BREO ELLIPTA Fluticasone Furoate and Vilanterol Label: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96428df1-ea05-431a-98d3-1ec2c4b63878
- MedlinePlus – Fluticasone and Vilanterol Oral Inhalation: https://medlineplus.gov/druginfo/meds/a613048.html
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Consult a qualified specialist or physician before using Fluticasone Furoate-Vilanterol.
Prescription Required (Rx) to Buy?
This medication is not available over the counter. A valid prescription from a licensed healthcare
professional is required. Always consult your doctor before use.
| Quantity | 120, 30, 60, 90 |
|---|---|
| Indication | COPD |
| Active Ingredient | Fluticasone Furoate + Vilanterol |
| Pharmaceutical Form | Tablets |
| Manufacturer | Cipla Limited |
| Indian Brand | Voltido 100mcg/25mcg 15's |
| US Brand Name | Breo Ellipta |
| Generic Name | Fluticasone Furoate + Vilanterol |
| Dosage | 100mcg-25mcg |
| Drug Type | Tablets |
